SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 155 filers reported holding SERES THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $256,117 | -43.5% | 107,612 | +34.5% | 0.00% | -50.0% |
| Q1 2023 | $453,600 | +41.3% | 80,000 | +60.0% | 0.01% | +100.0% |
| Q3 2022 | $321,000 | +86.6% | 50,000 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $172,000 | -90.3% | 50,000 | -80.0% | 0.00% | -90.9% |
| Q1 2022 | $1,780,000 | +249.0% | 250,000 | +241.3% | 0.02% | +266.7% |
| Q3 2021 | $510,000 | -91.5% | 73,250 | -70.7% | 0.01% | -92.3% |
| Q2 2021 | $5,965,000 | +428.3% | 250,136 | +356.5% | 0.08% | +225.0% |
| Q1 2021 | $1,129,000 | -88.2% | 54,800 | -83.8% | 0.02% | -89.3% |
| Q3 2020 | $9,572,000 | +4911.5% | 338,100 | +745.2% | 0.22% | +3633.3% |
| Q2 2020 | $191,000 | – | 40,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 14,378,802 | $342,935,000 | 4.38% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 122,700 | $2,926,000 | 1.30% |
| COMMODORE CAPITAL LP | 145,453 | $3,469,000 | 1.21% |
| Asymmetry Capital Management, L.P. | 63,259 | $1,509,000 | 1.04% |
| Opaleye Management Inc. | 250,000 | $5,963,000 | 0.99% |
| Ikarian Capital, LLC | 500,000 | $11,924,000 | 0.96% |
| HighVista Strategies LLC | 44,750 | $1,068,000 | 0.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 63,915 | $1,524,000 | 0.68% |
| Altium Capital Management LP | 104,626 | $2,495,000 | 0.58% |
| Integral Health Asset Management, LLC | 75,000 | $1,789,000 | 0.49% |